Source: Annual Congress 2009 - Treatment of tuberculosis at times of emerging drug resistance
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
I. A. Vasilyeva, V. I. Chukanov, T. R. Bagdasaryan (Moscow, Russian Federation). The experience of complex treatment of XDR-TB patients. Eur Respir J 2009; 34: Suppl. 53, 213

Member's Comments

No comment yet.

Related content which might interest you: Linezolide in complex treatment of XDR-TB patients Source: Annual Congress 2011 - Treatment of tuberculosis and adverse drug reactions Year: 2011 Experience of Bedaquiline use in treatment of XDR-TB patients Source: International Congress 2017 – TB: diagnosis, severity and practical management Year: 2017 Early outcomes in MDR-TB and XDR-TB patients treated with delamanid under compassionate use Source: Eur Respir J, 50 (1) 1700311; 10.1183/13993003.00311-2017 Year: 2017 Impact of XDR-TB on treatment outcome of MDR-TB patients with standardized regimens Source: Annual Congress 2008 - The challenge of multidrug-resistant tuberculosis Year: 2008 DOTS-Plus treatment of MDR-TB patients with psychiatric disorders Source: Annual Congress 2007 - New methods to diagnose tuberculosis infection and disease and problems in tuberculosis care Year: 2007 Treatment outcomes for XDR TB patients with surgery Source: Annual Congress 2007 - Multidrug-resistant tuberculosis and the emerging threat of extensively drug-resistant tuberculosis Year: 2007 Impact of pre-treatment duration by first line drugs on treatment outcomes of patients with MDR-TB Source: International Congress 2015 – TB treatment: new drugs and drug resistance Year: 2015 The incidence of multi drug resistant tuberculosis among patients receiving standardized treatment regimen for suspected MDR-TB Source: Annual Congress 2012 - MDR- and XDR-TB: clinical and public health experiences Year: 2012 The relapses of tuberculosis with multiple drug resistance among patients treated under DOTS-Plus regimen Source: Annual Congress 2010 - Tuberculosis drug resistance Year: 2010 Treatment results for MDR TB patients after surgery Source: Eur Respir J 2005; 26: Suppl. 49, 654s Year: 2005 Treatment outcomes of extensively-drug resistant tuberculosis (XDR-TB) patients in 20 countries Source: Annual Congress 2012 - Pros and cons of MDR- and XDR-TB treatment Year: 2012 The depressive syndrome as a response to the TB treatment in MDR TB patients Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis III Year: 2008 The clinical features and treatment of cases with MDR TB of adolescents Source: Annual Congress 2007 - Specific problems in caring for multidrug-resistant tuberculosis and tuberculosis/HIV cases Year: 2007 MDR-TB treatment in prison setting Source: Annual Congress 2007 - Tuberculosis control in the penitentiary and civilian sector Year: 2007 Managing adult and children XDR-TB cases with limited clinical options Source: International Congress 2018 – CC4 Tuberculosis Year: 2018 Final treatment outcomes of multidrug- and extensively drug-resistant tuberculosis patients in Latvia receiving delamanid-containing regimens Source: Eur Respir J, 50 (5) 1701105; 10.1183/13993003.01105-2017 Year: 2017 Psychiatric issues during the treatment of the patients with multidrug-resistant tuberculosis Source: Annual Congress 2005 - Resistant and multidrug resistant tuberculosis Year: 2005 The assessment of the efficacy of a standard chemotherapy regimen in the treatment of new sputum-positive tuberculosis (TB) patients Source: Eur Respir J 2001; 18: Suppl. 33, 340s Year: 2001 MDR-TB and XDR-TB: drug resistance and treatment outcomes Source: Eur Respir J 2009; 34: 778 Year: 2009